SNP 630

Drug Profile

SNP 630

Alternative Names: SNP-630

Latest Information Update: 20 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sinew Pharma
  • Class Hepatoprotectants; Immunoconjugates
  • Mechanism of Action Cytochrome P 450 enzyme system inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Non-alcoholic steatohepatitis

Most Recent Events

  • 20 Jul 2017 Preclinical trials in Non-alcoholic steatohepatitis in Taiwan before July 2017 (Sinew Pharma pipeline, July 2017)
  • 20 Jul 2017 Sinew Pharma announces intention to submit application for IND, fast track designation and breakthrough therapy designation to US FDA for Non-alcoholic steatohepatitis (Sinew Pharma pipeline, July 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top